Table 1 Regression analysis for the outcomes
Outcomes | Before propensity score | After propensity score | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Control (650 patients) | Thiamine (88 patients) | P value | Odds Ratio (OR) (95% CI) | P value | Control (83 patients) | Thiamine (83 patients) | P value | Odds ratio (OR) (95% CI) | P value | |
30-day mortality, n (%)# | 264 (40.6) | 18 (20.5) | 0.002^^ | 0.45 (0.24,0.84) | 0.01*^ | 30 (36.1) | 15 (18.1) | 0.009^^ | 0.37 (0.18,0.78) | 0.009$ |
In-hospital mortality, n (%)# | 313 (48.2) | 22 (25) | 0.009^^ | 0.37 (0.18,0.78) | 0.009*^ | 35 (42.2) | 19 (22.9) | 0.008^^ | 0.39 (0.19,0.78) | 0.008$ |
Beta coefficient (95% CI) | P value | Beta coefficient (95% CI) | P value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
MV duration during ICU, Median (Q1, Q3) &# | 10.0 (4.0, 17.0) | 7.0 (3.0, 16.0) | 0.17^ | 0.02 (− 0.24, 0.30) | 0.84*^ | 11.0 (5.0, 20.0) | 7.0 (3.0, 20.0) | 0.68^ | − 0.13 (− 0.54, 0.27) | 0.51$* |
ICU Length of Stay (Days), Median (Q1, Q3) & | 8.0 (5.0, 14.0) | 8.0 (5.0,13.0) | 0.89^ | 0.07 (− 0.12, 0.27) | 0.49*^ | 8.0 (4.0, 12.0) | 8.0 (5.0, 13.0) | 0.78^ | 0.11 (− 0.19, 0.39) | 0.48$* |
Hospital Length of Stay (Days), Median (Q1, Q3)& | 17.0 (11.0, 26.5) | 15.0 (10.0, 24.5) | 0.47^ | 0.04 (− 0.12,0.21) | 0.59*^ | 13.0 (11.0, 21.0) | 15.0 (10.0, 25.0) | 0.30^ | 0.08 (− 0.17,0.33) | 0.52$* |